Rapid Fentanyl (FYL) Test Strip, Rapid Fentanyl (FYL) Test Dipcard

The Rapid Fentanyl Test Strip and Dipcard are specifically designed for clinical toxicology settings, where rapid, point-of-care detection of fentanyl in human urine is critical. Unlike broader drug screening tests, these devices are enzyme immunoassay-based and are qualitatively targeted only for fentanyl, distinguishing them from multi-drug panels. They provide a fast, on-site result to help assess potential fentanyl exposure, which is particularly relevant in emergency departments, poison control centers, or forensic toxicology labs.

No, the Rapid Fentanyl Test Strip and Dipcard are intended for single-use only, as explicitly stated in the device description. This means each test must be discarded after use, which impacts workflow efficiency but ensures accuracy and avoids cross-contamination. Clinicians should account for this in their testing protocols, particularly in high-volume settings, to maintain proper inventory and reduce waste management complexity.

The manufacturer specifies no special storage conditions beyond standard guidelines for immunoassay devices. This means they can be stored at room temperature (typically 15–30°C or 59–86°F) without refrigeration, simplifying inventory management for clinical labs. However, users should still follow the manufacturer’s instructions to avoid exposure to extreme temperatures, humidity, or direct sunlight, which could compromise test performance.

The Rapid Fentanyl Test Strip and Dipcard are authorized under FDA 510(k) clearance (K231904) and regulated under FDA regulation number 862.3650, which classifies them as enzyme immunoassay devices for opiates. The clearance indicates they are substantially equivalent to a predicate device and meet FDA requirements for safety and effectiveness in their intended use—qualitative detection of fentanyl in human urine for clinical toxicology. When purchasing, verify the device’s registration number (e.g., 3010934853) matches the FDA’s database to confirm compliance.

Both formats—test strip and test dipcard—serve the same purpose (qualitative fentanyl detection in urine) but may differ in usability based on workflow preferences. The strip format is typically more portable and easier to handle in field or emergency settings, while the dipcard format may offer a larger test area or clearer visual readout for labs prioritizing precision. Neither is sterile, so selection should also consider ease of use, sample volume requirements, and whether your lab prefers disposable strips or cards for batch testing.